| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |